ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,117Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 336

$1.36M Total Retail Price of All Prescriptions

Rank: 13 out of 336

1,126 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 1,126 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

24% of this provider’s 1,126 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 16,950 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 1,164 723 S3 1 2
OMEPRAZOLE 604 485 2 3
FUROSEMIDE 559 442 3 4
AMLODIPINE BESYLATE 517 382 4 1
GABAPENTIN 472 269 5 11
SIMVASTATIN 440 355 6 5
LISINOPRIL 413 318 7 6
LEVOTHYROXINE SODIUM 393 311 8 7
POTASSIUM CHLORIDE 357 292 9 9
MELOXICAM 351 264 10 19
TRAMADOL HCL 350 175 11 20
LACTULOSE 326 242 12 143
WARFARIN SODIUM 312 273 13 17
METFORMIN HCL 290 184 14 8
RANITIDINE HCL 270 203 15 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 260 183 16 23
KLOR-CON M20 260 203 16 51
SERTRALINE HCL 251 225 18 33
METOPROLOL TARTRATE 249 207 19 16
PRAVASTATIN SODIUM 245 206 20 10
AZITHROMYCIN 235 155 21 58
CLOPIDOGREL 235 212 21 28
PREDNISONE 217 145 23 48
DONEPEZIL HCL 215 205 24 27
METOPROLOL SUCCINATE 205 153 25 15
TRAZODONE HCL 202 155 26 46
FLUTICASONE PROPIONATE 199 142 27 49
DIOVAN 189 149 28 31
GLIMEPIRIDE 189 140 28 29
CARVEDILOL 189 136 28 13
HYDRALAZINE HCL 178 128 31 53
METFORMIN HCL ER 176 114 32 61
NAMENDA 174 150 33 39
PLAVIX 173 147 34 37
BUMETANIDE 166 120 35 116
FENOFIBRATE 160 102 36 72
TAMSULOSIN HCL 159 111 37 38
CIPROFLOXACIN HCL 159 138 37 55
METOCLOPRAMIDE HCL 155 115 39 123
ATORVASTATIN CALCIUM 154 119 40 14
CITALOPRAM HBR 154 119 40 21
HYDROCHLOROTHIAZIDE 150 131 42 12
CLONIDINE HCL 145 100 43 32
NEXIUM 142 106 44 24
QUETIAPINE FUMARATE 141 128 45 94
ZOLPIDEM TARTRATE 139 93 46 18
RISPERIDONE 134 108 47 90
DIOVAN HCT 132 82 48 41
FENTANYL 123 112 S2 49 120
ENALAPRIL MALEATE 116 107 50 60
ONDANSETRON HCL 115 103 51 273
CRESTOR 113 80 52 25
ISOSORBIDE MONONITRATE ER 112 109 53 44
AGGRENOX 112 75 53 133
POLYETHYLENE GLYCOL 3350 111 101 55 68
CARBIDOPA-LEVODOPA 109 89 56 150
LYRICA 106 55 57 70
SPIRIVA 106 92 57 88
CLOTRIMAZOLE-BETAMETHASONE 104 72 59 146
MIRTAZAPINE 103 74 60 66
LOVASTATIN 103 66 60 34
SULFAMETHOXAZOLE-TRIMETHOPRIM 102 65 62 89
AMITRIPTYLINE HCL 102 69 R 62 57
ALLOPURINOL 101 79 64 30
GLIPIZIDE 100 87 65 71
LEVOFLOXACIN 100 81 65 93
PHENYTOIN SODIUM EXTENDED 99 49 67 97
PROAIR HFA 95 57 68 77
MECLIZINE HCL 94 88 69 96
DEXILANT 94 37 69 147
VERAPAMIL ER 91 76 71 95
HUMALOG 87 81 72 214
SPIRONOLACTONE 87 45 72 42
PAROXETINE HCL 86 58 74 64
AMILORIDE-HYDROCHLOROTHIAZIDE 85 52 75 208
LANTUS SOLOSTAR 84 73 76 124
COLCRYS 84 53 76 103
ADVAIR DISKUS 83 62 78 82
LANTUS 82 54 79 56
TIZANIDINE HCL 82 28 79 83
LOSARTAN POTASSIUM 80 60 81 22
PANTOPRAZOLE SODIUM 80 73 81 40
ATENOLOL 80 67 81 26
SUCRALFATE 79 69 84 192
NITROGLYCERIN PATCH 78 78 85 201
PEN NEEDLE 77 62 86 162
CILOSTAZOL 73 63 87 158
SODIUM CHLORIDE 71 67 88 348
AMLODIPINE BESYLATE-BENAZEPRIL 71 54 88 47
FLUOXETINE HCL 69 55 90 81
COMBIVENT 69 41 90 152
SYMBICORT 68 44 92 155
AMOXICILLIN 66 46 93 128
GLYBURIDE 66 62 R 93 76
PREMARIN 66 34 R 93 131
LEVETIRACETAM 66 31 93 114
VENLAFAXINE HCL ER 64 40 97 100
INSULIN SYRINGE 62 34 98 102
HUMULIN 70-30 62 39 98 173
OXYBUTYNIN CHLORIDE ER 62 53 98 186
ESCITALOPRAM OXALATE 60 44 101 69
BYSTOLIC 60 60 101 79
CYCLOBENZAPRINE HCL 60 22 R 101 65
METOLAZONE 60 53 101 170
CEFTRIAXONE 60 49 101 257
DOXYCYCLINE HYCLATE 59 34 106 92
MEGESTROL ACETATE 59 51 R 106 110
JANUVIA 58 32 108 67
CELEBREX 58 52 108 105
IBUPROFEN 57 36 110 118
RESTASIS 57 36 110 302
DIGOXIN 56 50 112 50
CYMBALTA 55 17 113 52
LAMOTRIGINE 53 30 114 242
IPRATROPIUM-ALBUTEROL 52 37 115 232
TRIAMTERENE-HCTZ 51 41 116 35
DILTIAZEM ER 51 28 116 138
GENERLAC 51 43 116 270
NITROSTAT 50 28 119 198
PROCHLORPERAZINE MALEATE 50 39 119 388
ROPINIROLE HCL 50 43 119 98
GLYBURIDE-METFORMIN HCL 50 22 R 119 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.